首页   按字顺浏览 期刊浏览 卷期浏览 Antimuscarinic properties of vamicamide, a novel compound for the treatment of pollakiu...
Antimuscarinic properties of vamicamide, a novel compound for the treatment of pollakiuria

 

作者: Takao Yamamoto,   Masahiko Matsuo,   Shunji Yamazaki,   Koji Ueshima,   Tadashi Sawada,   Atsuko Furuichi,   Reiko Ozaki,   Misako Nishii,   Shintaro Miura,   Takahiro Kusunoki,   Natsuki Sato,   Yasushi Koibuchi,   Kimio Esumi,   Minoru Ohtsuka,  

 

期刊: Drug Development Research  (WILEY Available online 1995)
卷期: Volume 34, issue 1  

页码: 9-18

 

ISSN:0272-4391

 

年代: 1995

 

DOI:10.1002/ddr.430340103

 

出版商: Wiley Subscription Services, Inc., A Wiley Company

 

关键词: competitive binding;bladder;contracture;muscarinic receptor

 

数据来源: WILEY

 

摘要:

AbstractThe antimuscarinic profile of vamicamide, a novel compound for the treatment of pollakiuria, was investigated in both in vitro and in vivo preparations. Vamicamide (10 nM–10 μM) inhibited the contractile response of isolated guinea‐pig detrusor muscle to transmural electrical stimulation. In isolated guinea‐pig detrusor muscle, vamicamide also inhibited contractile response to carbachol with an IC50value of 0.71 μM, whereas it had little or no effect on detrusor contractions induced by KCl, BaCl2, or α, β‐methylene ATP. In binding studies with dog membrane preparations, the dissociation constant (Ki) of vamicamide against tritiated N‐methylscopolamine ([3H]NMS) binding was 172 ± 8 nM for the urinary bladder, which was lower (P<0.01) than those for the heart (322 ± 31 nM), stomach (317 ± 29 nM), and salivary gland (321 ± 32 nM). The Ki value for the cerebral cortex (95 ± 4 nM) tended to be lower than that for the urinary bladder. In binding studies with cloned human muscarinic receptor subtypes (m1–m3), the dissociation constant (Ki) of vamicamide against [3H]NMS binding was 89.0 ± 3.5 nM for the m3 receptor subtype, which was lower than those for the m1 (235 ± 5 nM,P<0.05) and m2 (593 ± 49 nM,P<0.01) receptor subtypes. In anesthetized dogs, vamicamide (3.2–100 μg/kg; 11–336 nmol/kg, iv) inhibited the carbachol‐induced contractile responses of the urinary bladder with an ID50value of 16.1 μg/kg (54 nmol/kg), the stomach with a value of 31.3 μg/kg (105 nmol/kg), the descending colon with a value of 10.1 μg/kg (34 nmol/kg), and secretory response of the salivary gland to carbachol with a value of 43.3 μg/kg (146 nmol/kg); the inhibitory effects of the compound on the stomach and salivary gland were weaker (P<0.01) than that on the urinary bladder. Furthermore, duration of the action of vamicamide was longer on the urinary bladder and descending colon than those on the stomach and salivary gland. These results suggest that vamicamide has a selective binding affinity to the muscarinic m3 receptor subtype and exhibits greater and longer inhibitory action on the urinary bladder than the other

 

点击下载:  PDF (798KB)



返 回